CARBOGEN AMCIS, based in Bubendorf, Switzerland, and owned by India's Dishman Carbogen Amcis Limited, is a CDMO providing seamless drug substance and drug product development and commercialization services for pharmaceutical and biopharmaceutical companies worldwide, including North and South America, Western and Eastern Europe, Australasia, Asia and the Middle East. The company operates a fully cGMP-compliant infrastructure that includes dedicated Highly Potent API facilities and a clean room for antibody drug conjugates, and it also supplies high-quality cholesterol and vitamin D analogs. It offers OEM services and is recognized for its experienced R&D staff, contract manufacturing capability and quality of service.
Aucun commentaire disponible.
Laissez votre note & commentaire